Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized |
Target | IFN-α |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6486H9990N1722O2026S44 |
Molar mass | 145917.93 g·mol−1 |
NY (what is this?) (verify) |
Rontalizumab is a humanized monoclonal antibody[1] being developed by Genentech.[2] As of November 2009[update], it is being investigated in a clinical trial for the treatment of systemic lupus erythematosus.[3][4]
| |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemokine |
| ||||||||||||
CSF |
| ||||||||||||
Interferon |
| ||||||||||||
Interleukin |
| ||||||||||||
TGFβ |
| ||||||||||||
TNF |
| ||||||||||||
Others |
|
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
This antineoplasticorimmunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |